Rachlin Evan Lockwood
Insider CIK 2151678 · IAM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 410,762 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 306,711 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 57,754 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,152,025 | — | $0 | 0 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 57,754 | — | — | 57,754 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | P Buy | 2026-10-16 | 2026-10-19 | 718,750 | $16.00 | $11.50M | 2,588,248 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 410,762 | — | — | 1,869,498 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | C Conversion | 2026-10-16 | 2026-10-19 | 1,458,736 | — | — | 1,458,736 | SEC↗ |
| IAM Iambic Therapeutics, Inc. | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |